Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Wilkinson

Showing results (1-10 of 393) with videos related to

Pageof 40
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 14, 2020
Tuberculosis and Type 2 Diabetes Mellitus: An Inflammatory Danger Signal in the Time of Coronavirus Disease 2019Robert J Wilkinson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 2010
Undiagnosed active tuberculosis in HIV-infected patients commencing antiretroviral therapyGraeme Meintjes, Robert J Wilkinson
Lancet (London, England)|August 28, 2007
TuberculosisGary Maartens, Robert J Wilkinson
Annals of the American Thoracic Society|May 2, 2017
Minimizing Tuberculosis Risk in Patients Receiving Anti-TNF TherapyHanif Esmail, Robert J Wilkinson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2010
Optimum timing of antiretroviral therapy for HIV-infected patients with concurrent serious opportunistic infectionsGraeme Meintjes, Robert J Wilkinson
Ebiomedicine|February 13, 2016
Are the Present Doses of Anti Tubercular Drugs Adequate for Severe Disease?Suzaan Marais, Robert J Wilkinson
Methods in Molecular Biology (Clifton, N.J.)|July 7, 2025
A 3D In Vitro Blood-Brain Barrier Model to Study Pathogen and Drug Effects on the BBBAlizé Proust, Robert J Wilkinson
European Journal of Immunology|September 21, 2010
Polyfunctional T cells in human tuberculosisKatalin A Wilkinson, Robert J Wilkinson
The Lancet. HIV|October 2, 2015
ART and prevention of HIV-associated tuberculosisStephen D Lawn, Robert J Wilkinson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2007
Evidence guiding the treatment of children with mycobacterial diseasesMark P Nicol, Robert J Wilkinson
Pageof 40

Showing results (1-10 of 393) with videos related to

Sort By:
Pageof 40
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 14, 2020
Tuberculosis and Type 2 Diabetes Mellitus: An Inflammatory Danger Signal in the Time of Coronavirus Disease 2019Robert J Wilkinson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 2010
Undiagnosed active tuberculosis in HIV-infected patients commencing antiretroviral therapyGraeme Meintjes, Robert J Wilkinson
Lancet (London, England)|August 28, 2007
TuberculosisGary Maartens, Robert J Wilkinson
Annals of the American Thoracic Society|May 2, 2017
Minimizing Tuberculosis Risk in Patients Receiving Anti-TNF TherapyHanif Esmail, Robert J Wilkinson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2010
Optimum timing of antiretroviral therapy for HIV-infected patients with concurrent serious opportunistic infectionsGraeme Meintjes, Robert J Wilkinson
Ebiomedicine|February 13, 2016
Are the Present Doses of Anti Tubercular Drugs Adequate for Severe Disease?Suzaan Marais, Robert J Wilkinson
Methods in Molecular Biology (Clifton, N.J.)|July 7, 2025
A 3D In Vitro Blood-Brain Barrier Model to Study Pathogen and Drug Effects on the BBBAlizé Proust, Robert J Wilkinson
European Journal of Immunology|September 21, 2010
Polyfunctional T cells in human tuberculosisKatalin A Wilkinson, Robert J Wilkinson
The Lancet. HIV|October 2, 2015
ART and prevention of HIV-associated tuberculosisStephen D Lawn, Robert J Wilkinson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2007
Evidence guiding the treatment of children with mycobacterial diseasesMark P Nicol, Robert J Wilkinson
Pageof 40